CN220597233U - Processing system for recycling organic phosphine in pharmaceutical industry - Google Patents
Processing system for recycling organic phosphine in pharmaceutical industry Download PDFInfo
- Publication number
- CN220597233U CN220597233U CN202321667398.5U CN202321667398U CN220597233U CN 220597233 U CN220597233 U CN 220597233U CN 202321667398 U CN202321667398 U CN 202321667398U CN 220597233 U CN220597233 U CN 220597233U
- Authority
- CN
- China
- Prior art keywords
- reverse osmosis
- organic phosphine
- recycling
- produced water
- water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- XYFCBTPGUUZFHI-UHFFFAOYSA-N Phosphine Chemical compound P XYFCBTPGUUZFHI-UHFFFAOYSA-N 0.000 title claims abstract description 68
- 229910000073 phosphorus hydride Inorganic materials 0.000 title claims abstract description 34
- 238000004064 recycling Methods 0.000 title claims abstract description 24
- 238000012545 processing Methods 0.000 title claims description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 60
- 238000001223 reverse osmosis Methods 0.000 claims abstract description 39
- 239000002351 wastewater Substances 0.000 claims abstract description 26
- 238000000108 ultra-filtration Methods 0.000 claims abstract description 21
- 238000001704 evaporation Methods 0.000 claims abstract description 15
- 230000008020 evaporation Effects 0.000 claims abstract description 15
- 239000004576 sand Substances 0.000 claims abstract description 13
- 238000001914 filtration Methods 0.000 claims abstract description 8
- 238000009287 sand filtration Methods 0.000 claims abstract description 7
- 239000012535 impurity Substances 0.000 claims abstract description 6
- 239000012528 membrane Substances 0.000 claims description 22
- 239000010826 pharmaceutical waste Substances 0.000 claims description 3
- 150000003003 phosphines Chemical class 0.000 claims 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 13
- 229910052698 phosphorus Inorganic materials 0.000 description 13
- 239000011574 phosphorus Substances 0.000 description 13
- 238000000034 method Methods 0.000 description 10
- 238000005516 engineering process Methods 0.000 description 6
- 238000011161 development Methods 0.000 description 4
- 230000018109 developmental process Effects 0.000 description 4
- 239000007788 liquid Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 238000010612 desalination reaction Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000013535 sea water Substances 0.000 description 2
- 239000010865 sewage Substances 0.000 description 2
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000010170 biological method Methods 0.000 description 1
- 238000009388 chemical precipitation Methods 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000012851 eutrophication Methods 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 239000010842 industrial wastewater Substances 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000001728 nano-filtration Methods 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 238000004094 preconcentration Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000010802 sludge Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229910021642 ultra pure water Inorganic materials 0.000 description 1
- 239000012498 ultrapure water Substances 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Landscapes
- Separation Using Semi-Permeable Membranes (AREA)
Abstract
The utility model provides a treatment system for recycling organic phosphine in pharmaceutical industry, which is used for treating organic phosphine-containing pharmaceutical wastewater and comprises a wastewater collection tank, a sand filtration device, an ultrafiltration device, a reverse osmosis device and a low-temperature evaporation device which are sequentially connected through pipelines; the produced water outlet of the reverse osmosis device is communicated with a produced water collecting tank; the sand filtering device is used for removing impurities and suspended matters in homogenized pharmaceutical wastewater containing organic phosphine; the ultrafiltration device is used for removing microsuspension and particulate matters in produced water of the sand filtration device so as to meet the water inlet requirement of the reverse osmosis device; the reverse osmosis device is used for carrying out concentration and reduction treatment on the produced water of the ultrafiltration device; the low-temperature evaporation device is used for further concentrating the reverse osmosis concentrated solution. The treatment system for the pharmaceutical wastewater containing the organic phosphine provided by the utility model effectively realizes recycling and utilization, is environment-friendly, and has economic value and social value.
Description
Technical Field
The utility model belongs to the field of wastewater reclamation, and particularly relates to a treatment system for recycling organic phosphine in the pharmaceutical industry.
Background
In most industries of the 21 st century, membrane technology will play an important role in the fields of water resources, energy, environment, traditional industrial reformation, etc. The water treatment membrane technology is to remove impurities in water by utilizing the substance separation effect of a biological membrane so as to realize the aim of purification treatment. Different types of biological membranes differ in their function in water treatment, such as: the bipolar membrane is used for treating fluorine-containing waste liquid, and the nanofiltration membrane is used for sea water desalination and the like. Therefore, the membrane technology has good development prospect in the field of water treatment, and the analysis of the current development state and trend can promote the development of the water treatment membrane technology. Reverse osmosis technology has become the most economical means for desalination of sea water and brackish water, preparation of pure water and ultrapure water and material preconcentration, and membrane treatment technology has wide development prospect.
Phosphorus is a root cause of eutrophication of water, for example, if the phosphorus contained in industrial wastewater is directly discharged without treatment, the water environment can be directly polluted, and the overall environment is adversely affected. The existing methods for removing phosphorus from sewage mainly comprise a biological method, an ion exchange method, a chemical precipitation method and the like, and the traditional biological treatment process is simple to operate, but the overall removal rate is low, so that the requirements of water outlet are difficult to directly meet; although the ion exchange resin can selectively remove phosphorus in the sewage, the processes such as resin regeneration and the like, including the process and the use of medicaments, lengthen the whole process chain and complicate the operation; the chemical laws are that the cost of chemical sludge treatment after its treatment is too high, and therefore, the dephosphorization process/system needs to be optimized.
Disclosure of Invention
The utility model aims at providing a membrane treatment system for pharmaceutical wastewater containing organic phosphine.
For this purpose, the above object of the present utility model is achieved by the following technical solutions:
the utility model provides a processing system that organic phosphine of pharmaceutical industry was retrieved, processing system that organic phosphine of pharmaceutical industry was retrieved was used for handling and contains organic phosphine pharmacy waste water, its characterized in that: the treatment system for recycling the organic phosphine in the pharmaceutical industry comprises a wastewater collection tank, a sand filtering device, an ultrafiltration device, a reverse osmosis device and a low-temperature evaporation device which are sequentially connected through pipelines;
the produced water outlet of the reverse osmosis device is communicated with a produced water collecting tank;
the waste water collecting tank is used for homogenizing the pharmaceutical waste water containing the organic phosphine;
the sand filtering device is used for removing impurities and suspended matters in homogenized pharmaceutical wastewater containing organic phosphine;
the inlet of the ultrafiltration device is communicated with the produced water outlet of the sand filtration device, and the ultrafiltration device is used for removing micro suspended matters and particulate matters in the produced water of the sand filtration device so as to meet the water inlet requirement of the reverse osmosis device;
the inlet of the reverse osmosis device is communicated with the produced water outlet of the ultrafiltration device, and the reverse osmosis device is used for carrying out concentration and reduction treatment on the produced water of the ultrafiltration device;
the inlet of the low-temperature evaporation device is communicated with the concentrated water outlet of the reverse osmosis device, and the low-temperature evaporation device is used for further concentrating the reverse osmosis concentrated solution.
The utility model can also adopt or combine the following technical proposal when adopting the technical proposal:
as a preferred technical scheme of the utility model: the sand filter device is a multi-medium filter.
As a preferred technical scheme of the utility model: the water outlet of the reverse osmosis device is also connected with a recycling water tank, and the recycling water tank is used for storing the water produced by the reverse osmosis device for recycling.
As a preferred technical scheme of the utility model: the reverse osmosis device is a triple type flat membrane machine or a coiled membrane machine.
The utility model provides a processing system for recycling organic phosphine in the pharmaceutical industry, which has the following beneficial effects:
(1) The efficient interception of total phosphorus in the pharmaceutical wastewater containing organic phosphine can be realized through the effective combination of the sand filtering device, the ultrafiltration device, the reverse osmosis device and the low-temperature evaporation device, so that the interception rate of the total phosphorus in the membrane concentrate is as high as more than 99 percent, wherein the interception rate of the total phosphorus refers to the percentage of the total phosphorus content in the membrane concentrate and the total phosphorus content in raw water.
(2) The combination of the sand filtration device and the ultrafiltration device can remove most of large particulate matters and suspended matters in the organic phosphine-containing pharmaceutical wastewater, and impurities and suspended matters can be further removed through the ultrafiltration device so as to meet the membrane feeding requirement of the reverse osmosis device, thereby reducing the fouling phenomenon and the membrane cleaning frequency of the subsequent membrane process section.
(3) The treatment system for the pharmaceutical wastewater containing the organic phosphine provided by the utility model is based on the double-membrane method for treatment, effectively intercepts the total phosphorus content in the wastewater, has simple overall structure and connection relation, has high integration and automation degree, and is beneficial to industrial application.
(4) The product of the treatment system for the pharmaceutical wastewater containing the organic phosphine, which is provided by the utility model, can be used as a raw material to return to a production line after being concentrated by the low-temperature evaporation device, so that the material resource can be effectively recovered.
(5) The treatment system for the pharmaceutical wastewater containing the organic phosphine effectively realizes recycling and utilization, is environment-friendly, and has economic value and social value.
Drawings
Fig. 1 is a diagram of a processing system for recycling organic phosphine in the pharmaceutical industry.
Detailed Description
The utility model will be described in further detail with reference to the drawings and specific embodiments.
A treatment system for recycling organic phosphine in pharmaceutical industry is used for treating pharmaceutical wastewater containing organic phosphine, in the embodiment, the test is mainly carried out on the organic phosphine pharmaceutical wastewater, the aim is to remove total phosphorus in raw wastewater, recycling of produced water is achieved, recycling of concentrated solution is achieved, the salt content of water is about 2000 ppm, COD is more than 10000 ppm, and total phosphorus is less than 1000 ppm.
The resource recovery system of the organic phosphine in the pharmaceutical industry comprises a wastewater collection tank, a sand filtering device, an ultrafiltration device, a reverse osmosis device and a low-temperature evaporation device which are sequentially connected through pipelines; the produced water outlet of the reverse osmosis device is communicated with a produced water collecting tank;
the produced water outlet of the reverse osmosis device is communicated with a produced water collecting tank;
the waste water collecting tank is used for homogenizing the pharmaceutical waste water containing the organic phosphine;
the sand filtering device is used for removing impurities and suspended matters in the homogenized pharmaceutical wastewater containing the organic phosphine;
the inlet of the ultrafiltration device is communicated with the produced water outlet of the sand filter device, and the ultrafiltration device is used for removing micro suspended matters and particulate matters in produced water of the sand filter device so as to meet the water inlet requirement of the reverse osmosis device;
the inlet of the reverse osmosis device is communicated with the produced water outlet of the ultrafiltration device, and the reverse osmosis device is used for carrying out concentration and reduction treatment on the produced water of the ultrafiltration device;
the inlet of the low-temperature evaporation device is communicated with the concentrated water outlet of the reverse osmosis device, and the low-temperature evaporation device is used for further concentrating the reverse osmosis concentrated solution.
In this embodiment: the sand filter device is a multi-medium filter.
In this embodiment: the water producing port of the reverse osmosis device is connected with a reuse water tank, and the reuse water tank is used for storing the produced water of the reverse osmosis device for reuse.
In this embodiment: the reverse osmosis device is a triple type flat membrane machine or a roll membrane machine.
In this embodiment: the set temperature of the low-temperature evaporation device is 60-70 ℃. The low-temperature evaporation device can realize 2-3 times concentration of the phosphorus-rich solution.
The whole set of system realizes the high concentration of the organic phosphine, realizes the secondary recycling of the permeate liquid, realizes the recycling of the concentrated liquid, has great economic and social values, and has application and popularization significance.
The above embodiments are intended to illustrate the present utility model, but not limit the present utility model, and any modifications, equivalent substitutions, improvements, etc. made to the present utility model within the spirit of the present utility model and the scope of the claims are within the scope of the present utility model.
Claims (4)
1. The utility model provides a processing system that organic phosphine of pharmaceutical industry was retrieved, processing system that organic phosphine of pharmaceutical industry was retrieved was used for handling and contains organic phosphine pharmacy waste water, its characterized in that: the treatment system for recycling the organic phosphine in the pharmaceutical industry comprises a wastewater collection tank, a sand filtering device, an ultrafiltration device, a reverse osmosis device and a low-temperature evaporation device which are sequentially connected through pipelines;
the produced water outlet of the reverse osmosis device is communicated with a produced water collecting tank;
the waste water collecting tank is used for homogenizing the pharmaceutical waste water containing the organic phosphine;
the sand filtering device is used for removing impurities and suspended matters in homogenized pharmaceutical wastewater containing organic phosphine;
the inlet of the ultrafiltration device is communicated with the produced water outlet of the sand filtration device, and the ultrafiltration device is used for removing micro suspended matters and particulate matters in the produced water of the sand filtration device so as to meet the water inlet requirement of the reverse osmosis device;
the inlet of the reverse osmosis device is communicated with the produced water outlet of the ultrafiltration device, and the reverse osmosis device is used for carrying out concentration and reduction treatment on the produced water of the ultrafiltration device;
the inlet of the low-temperature evaporation device is communicated with the concentrated water outlet of the reverse osmosis device, and the low-temperature evaporation device is used for further concentrating the reverse osmosis concentrated solution.
2. The pharmaceutical industry organophosphine recycling treatment system according to claim 1, wherein: the sand filter device is a multi-medium filter.
3. The pharmaceutical industry organophosphine recycling treatment system according to claim 1, wherein: the water outlet of the reverse osmosis device is also connected with a recycling water tank, and the recycling water tank is used for storing the water produced by the reverse osmosis device for recycling.
4. A treatment system for the recycling of organic phosphines in the pharmaceutical industry according to claim 1 or 3, characterized in that: the reverse osmosis device is a triple type flat membrane machine or a coiled membrane machine.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202321667398.5U CN220597233U (en) | 2023-06-28 | 2023-06-28 | Processing system for recycling organic phosphine in pharmaceutical industry |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202321667398.5U CN220597233U (en) | 2023-06-28 | 2023-06-28 | Processing system for recycling organic phosphine in pharmaceutical industry |
Publications (1)
Publication Number | Publication Date |
---|---|
CN220597233U true CN220597233U (en) | 2024-03-15 |
Family
ID=90169665
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202321667398.5U Active CN220597233U (en) | 2023-06-28 | 2023-06-28 | Processing system for recycling organic phosphine in pharmaceutical industry |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN220597233U (en) |
-
2023
- 2023-06-28 CN CN202321667398.5U patent/CN220597233U/en active Active
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103803752B (en) | Treatment method of wastewater with high salinity and high organic matters | |
CN205603386U (en) | Strong brine zero release membrane concentrator | |
CN105585195A (en) | Coal chemical high-salinity wastewater treatment and recycling system | |
CN102936065A (en) | Method for treating wastewater | |
CN110950474A (en) | Phenol-cyanogen wastewater resource zero-discharge method and process | |
CN205603387U (en) | Strong brine zero release divides membrane concentrator of matter crystallization | |
CN201610402U (en) | Recycling and deep treatment device for electronic electroplating wastewater | |
CN203360192U (en) | Treatment device for difficultly degradable industrial wastewater | |
CN107200435A (en) | A kind of nickel-containing waste water processing method, processing system and application | |
CN101870639A (en) | Method for producing kelp mannitol with low energy consumption | |
CN104291501B (en) | A kind of Integrated Membrane Technology processes the method for ammonium nitrate wastewater | |
CN210528683U (en) | Wastewater zero discharge system capable of recycling waste acid, waste alkali and crystal salt | |
CN220597233U (en) | Processing system for recycling organic phosphine in pharmaceutical industry | |
CN116573806A (en) | Salt separation system combining reverse osmosis, electrodialysis and nanofiltration and application thereof | |
CN211394158U (en) | Electroplating effluent zero release sewage treatment plant | |
CN215102628U (en) | Processing system of concentrated water resourceization of high salt | |
CN212924700U (en) | Recycling process system for treating nitrogen and phosphorus-containing wastewater | |
CN214004331U (en) | Advanced treatment device for tail-end high-salinity wastewater of thermal power plant | |
CN113880293A (en) | Alkali reduction wastewater treatment method and treatment system | |
CN107117758A (en) | A kind of power plant desulfurization wastewater low consumption Zero discharge treatment method | |
CN112939342A (en) | Deep treatment method for hazardous waste packaging and cleaning wastewater | |
CN220745638U (en) | System for utilize boron-containing chemical industry reuse water preparation desalinized water | |
CN215886684U (en) | High multistage salt system that divides that contains salt waste water | |
CN218969053U (en) | Industrial wastewater zero release processing system | |
CN219972095U (en) | System for treating flushing wastewater of fishing port wharf |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
GR01 | Patent grant | ||
GR01 | Patent grant |